PureHealth Research Targets Cellular Aging
PureHealth Research is now targeting cellular aging pathways with its longevity supplements. The company is using advanced adaptogenic formulas in its products. This move aligns with growing consumer interest in supplements designed to promote longevity.
- The global market for anti-aging and longevity supplements is growing, with one projection estimating it will reach nearly $2.3 billion by 2030. Another forecast projects the anti-aging supplements market to reach approximately $9.95 billion by 2030, with a CAGR of 8.2%. - A key driver of this market growth is a consumer shift in focus from merely extending lifespan to enhancing "healthspan"—the period of life spent in good health. There's also a rising interest in "biohacking" and tracking cellular health markers. - PureHealth Research is a US-based company located in Manassas, Virginia. Its manufacturing processes are conducted in FDA-registered facilities. - The company's Youth Switch formula contains adaptogens like Ashwagandha, which has been studied for its potential effects on telomerase activity, the enzyme that helps maintain the length of telomeres. Telomeres are protective caps on the ends of DNA strands that shorten with each cell division, acting as a biological clock. - The formula also includes Cat's Claw, a botanical from the Amazon rainforest that researchers suggest may help protect DNA from environmental stressors. - Key competitors in the science-focused longevity supplement space include Elysium Health, which was founded by an MIT professor and has an advisory board with Nobel Prize winners, and Life Extension, which has a long-standing focus on evidence-based formulations. - There is an increasing consumer demand for supplements with transparent, science-backed ingredients that target the biological mechanisms of aging. This trend includes a growing interest in compounds like NAD+ precursors and senolytics.
